| First Author | Lim PX | Year | 2024 |
| Journal | Mol Cell | Volume | 84 |
| Issue | 3 | Pages | 447-462.e10 |
| PubMed ID | 38244544 | Mgi Jnum | J:346092 |
| Mgi Id | MGI:7614073 | Doi | 10.1016/j.molcel.2023.12.025 |
| Citation | Lim PX, et al. (2024) BRCA2 promotes genomic integrity and therapy resistance primarily through its role in homology-directed repair. Mol Cell 84(3):447-462.e10 |
| abstractText | Tumor suppressor BRCA2 functions in homology-directed repair (HDR), the protection of stalled replication forks, and the suppression of replicative gaps, but their relative contributions to genome integrity and chemotherapy response are under scrutiny. Here, we report that mouse and human cells require a RAD51 filament stabilization motif in BRCA2 for fork protection and gap suppression but not HDR. In mice, the loss of fork protection/gap suppression does not compromise genome stability or shorten tumor latency. By contrast, HDR deficiency increases spontaneous and replication stress-induced chromosome aberrations and tumor predisposition. Unlike with HDR, fork protection/gap suppression defects are also observed in Brca2 heterozygous cells, likely due to reduced RAD51 stabilization at stalled forks/gaps. Gaps arise from PRIMPOL activity, which is associated with 5-hydroxymethyl-2'-deoxyuridine sensitivity due to the formation of SMUG1-generated abasic sites and is exacerbated by poly(ADP-ribose) polymerase (PARP) inhibition. However, HDR proficiency has the major role in mitigating sensitivity to chemotherapeutics, including PARP inhibitors. |
